High Flow Nasal Cannula Compared to Standard Oxygen for Endoscopic Ultrasound
NCT ID: NCT06704867
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
200 participants
INTERVENTIONAL
2025-07-14
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HFNC Versus Conventional Oxygen Therapy in Prolonged Upper Gastrointestinal Endoscopy in the ICU
NCT06350864
Effect of High-Flow Nasal Cannula on IVC Measurements Using Point of Care Ultrasound
NCT05264454
Technique for Successful Ultrasound-guided Peripheral Vascular Access
NCT01975974
Ultrasound Guided Vascular Access in Pediatric Intensive Care Patients
NCT00207883
Patient Perspective Midline Catheter in the Emergency Department
NCT05607238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard oxygen therapy
Standard oxygen therapy will be initiated utilizing 2-4 liters of oxygen with a nasal cannula.
No interventions assigned to this group
High Flow Nasal Cannula
A high flow oxygen device with 100% FiO2 will be initiated prior to endoscopic ultrasound.
High flow nasal cannula
Subjects undergoing endoscopic ultrasound will receive high flow nasal cannula during the procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High flow nasal cannula
Subjects undergoing endoscopic ultrasound will receive high flow nasal cannula during the procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients undergoing combined procedure: Therapeutic EUS/combined procedures including EUS/ERCP, EUS/colonoscopy
* Patients on home oxygen therapy, or the diagnosis of "severe COPD"
* Patients with existing tracheostomy
* Inpatients undergoing EUS
* Inability to consent
* Cognitive impairment
* Blocked nasal passages
* Trauma/previous surgery to the nasopharynx
* Irregularities of the nose, face, or airway such that HFNC cannot be properly fitted
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fisher and Paykel Healthcare
INDUSTRY
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bhargavi Gali, M.D.
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bhargavi Gali, MD, MHA
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-003924
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.